TECOGEN INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TECOGEN INC. (NASDAQ: TGEN) on June 4, 2020. The filing addresses a significant corporate governance and market listing decision made by the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory disclosure regarding stock listing status rather than financial performance.
Material Changes
- Delisting from NASDAQ: The Company decided to delist its shares from the NASDAQ Stock Market LLC's Capital Market.
- OTC Transition: The Company will have its shares quoted on the OTC Market Group Inc.'s OTCQX Best Market.
- Deregistration: The Company intends to de-register its shares under Section 12(b) of the Securities Exchange Act of 1934.
Management Commentary and Risks
Management conducted a conference call on June 4, 2020, to discuss the decision to move from NASDAQ to the OTCQX Best Market. The filing notes that the information contained in Item 7.01 is for Regulation FD disclosure purposes and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the effective date of the delisting from NASDAQ and the commencement of trading on the OTCQX Best Market.
- Confirm the specific reasons for the delisting decision, which are detailed in the conference call recording (ID # 13672659) rather than this text.
- Review the Company's most recent 10-K or 10-Q filings for financial data, as this 8-K contains no financial metrics.
- Assess the impact of OTC trading on liquidity and market visibility compared to NASDAQ listing.